ESCA's Net Income Dips 2.8% Amidst Sales Decline, Tariff Headwinds

TL;DR

**ESCA's sales are slipping and tariffs are a looming threat; I'm staying on the sidelines for now.**

AI Summary

ESCALADE INC reported a slight decrease in net income for the nine months ended September 30, 2025, to $9.998 million, down from $10.286 million in the prior year, a 2.8% decline. Net sales for the nine-month period also decreased by 5.3% to $177.598 million from $187.568 million. However, for the three months ended September 30, 2025, net sales remained relatively flat at $67.786 million compared to $67.738 million in the same period of 2024. Operating income for the nine months fell to $13.574 million from $15.491 million, a 12.37% reduction, partly due to the absence of a $3.905 million gain on sale of assets held for sale recognized in 2024. The company identified a potential goodwill impairment indicator due to increased tariff-related costs, but an interim impairment test as of September 1, 2025, concluded that the fair value of the reporting unit still exceeded its carrying value by approximately 6%. Cash and cash equivalents decreased to $3.509 million at September 30, 2025, from $4.194 million at December 31, 2024. Long-term debt decreased from $18.452 million at December 31, 2024, to $13.095 million at September 30, 2025.

Why It Matters

ESCALADE's slight dip in net income and sales, coupled with a goodwill impairment warning due to tariffs, signals potential challenges for investors. While the company avoided impairment this quarter, the 6% buffer between fair value and carrying value is narrow, suggesting future tariff increases or economic downturns could impact shareholder value. Employees might face pressure if cost-cutting measures become necessary, and customers could see price adjustments. In a competitive sporting goods market, these financial pressures could affect ESCA's ability to invest in innovation and market share, potentially benefiting rivals.

Risk Assessment

Risk Level: medium — The company identified a potential goodwill impairment indicator due to increased tariff-related costs, and while no impairment occurred, the fair value of the reporting unit exceeded its carrying value by only approximately 6% as of September 1, 2025. This narrow margin indicates sensitivity to future cost increases or adverse events. Additionally, net sales for the nine months ended September 30, 2025, decreased by $9.970 million, or 5.3%, compared to the prior year, suggesting revenue generation challenges.

Analyst Insight

Investors should monitor ESCA's next earnings report closely for any further deterioration in sales or operating income, and pay particular attention to management's commentary on tariff impacts and strategies to mitigate these risks. Consider holding or reducing exposure until there's clearer evidence of revenue stabilization and a wider buffer against goodwill impairment.

Financial Highlights

debt To Equity

0.35

revenue

$177.598M

operating Margin

7.65%

total Assets

$232.460M

total Debt

$13.095M

net Income

$9.998M

cash Position

$3.509M

revenue Growth

-5.3%

Key Numbers

• $9.998M — Net Income (9 months ended Sep 30, 2025) (Decreased from $10.286M in prior year, a 2.8% decline.)
• $177.598M — Net Sales (9 months ended Sep 30, 2025) (Decreased from $187.568M in prior year, a 5.3% decline.)
• $67.786M — Net Sales (3 months ended Sep 30, 2025) (Relatively flat compared to $67.738M in prior year.)
• $13.574M — Operating Income (9 months ended Sep 30, 2025) (Decreased from $15.491M in prior year, a 12.37% decline.)
• 6% — Goodwill Fair Value Buffer (Fair value of reporting unit exceeded carrying value by approximately 6% as of September 1, 2025.)
• $3.509M — Cash and Cash Equivalents (Sep 30, 2025) (Decreased from $4.194M at December 31, 2024.)
• $13.095M — Long-term Debt (Sep 30, 2025) (Decreased from $18.452M at December 31, 2024.)
• $0.15 — Quarterly Dividend Per Share (Consistent dividend declared for multiple quarters in 2025.)

Key Players & Entities

• ESCALADE INC (company) — registrant
• Bloomberg (company) — publisher
• SEC (regulator) — filing authority
• NASDAQ Stock Market LLC (company) — exchange where ESCA is registered
• Financial Accounting Standards Board (company) — issuer of accounting standards
• ASC 350 (regulator) — accounting standard for goodwill
• ASU 2023-09 (regulator) — accounting standard for income tax disclosures
• Evansville, Indiana (location) — principal executive office

FAQ

Risk Factors

• Tariff-Related Cost Increases [medium — operational]: The company identified a potential goodwill impairment indicator due to increased tariff-related costs. While an interim impairment test as of September 1, 2025, showed the reporting unit's fair value exceeded its carrying value by approximately 6%, sustained increases in tariffs could pressure future profitability and asset valuations.
• Inventory Management Challenges [medium — market]: Inventories decreased to $80.662 million as of September 30, 2025, from $85.485 million in the prior year. However, the significant level of inventory suggests potential risks related to obsolescence, carrying costs, and the ability to adjust to changing market demand.
• Declining Operating Income and Net Sales [high — financial]: For the nine months ended September 30, 2025, net sales decreased by 5.3% to $177.598 million, and operating income fell by 12.37% to $13.574 million. This decline, partly due to the absence of a $3.905 million gain on sale of assets in the prior year, indicates potential headwinds in revenue generation and cost control.
• Reduced Cash Position [medium — financial]: Cash and cash equivalents decreased to $3.509 million at September 30, 2025, from $4.194 million at December 31, 2024. This reduction in liquidity could limit the company's flexibility for investments or managing short-term obligations.

Industry Context

Escalade Inc. operates in a competitive market influenced by consumer spending, raw material costs, and global trade dynamics. Recent increases in tariff-related costs suggest potential supply chain pressures affecting the broader industry. While the company's Q3 sales were flat, the year-to-date decline indicates broader market challenges or company-specific performance issues.

Regulatory Implications

The company must continue to monitor and disclose any material impacts from tariffs and trade policies, as these can affect costs and profitability. The goodwill impairment assessment highlights the need for ongoing evaluation of intangible asset values in the face of economic uncertainties.

What Investors Should Do

1. Monitor inventory levels and turnover ratios.
2. Analyze the drivers of the 12.37% decline in operating income.
3. Assess the sustainability of the current dividend.
4. Evaluate the impact of tariff costs on future margins.

Key Dates

• 2025-09-30: End of Q3 2025 — Reporting period for the 10-Q, showing decreased net sales and income compared to the prior year, but flat sales for the quarter.
• 2025-09-01: Interim Goodwill Impairment Test — Indicated a 6% buffer between fair value and carrying value, suggesting current resilience despite tariff cost concerns.
• 2024-09-30: End of Q3 2024 — Prior year comparison period, which included a $3.905 million gain on sale of assets, impacting year-over-year operating income comparisons.
• 2024-12-31: End of Fiscal Year 2024 — Baseline for comparing cash and debt levels, showing a decrease in both by Q3 2025.

Glossary

Goodwill

An intangible asset that arises when one company acquires another for a price greater than the fair market value of its net assets. (A potential indicator of impairment was noted due to increased costs, though the current fair value exceeds its carrying value.)

Operating Income

A measure of a company's profit after deducting operating expenses from its revenue. (Decreased by 12.37% for the nine-month period, impacted by the absence of a prior year asset sale gain.)

Net Sales

The total revenue generated from sales after deducting returns, allowances, and discounts. (Showed a 5.3% decline for the nine-month period, but remained relatively flat for the third quarter.)

Cash and cash equivalents

Includes cash on hand, bank account balances, and short-term, highly liquid investments. (Decreased to $3.509 million, indicating a reduction in readily available funds.)

Long-term debt

Financial obligations that are due more than one year from the balance sheet date. (Significantly reduced from $18.452 million at year-end 2024 to $13.095 million by September 30, 2025.)

Year-Over-Year Comparison

Compared to the prior year's nine-month period, Escalade Inc. reported a 5.3% decrease in net sales ($177.598M vs $187.568M) and a more significant 12.37% drop in operating income ($13.574M vs $15.491M), partly due to the non-recurrence of a $3.905M asset sale gain. While net income saw a smaller 2.8% decline ($9.998M vs $10.286M), the company's cash position has weakened, and long-term debt has been reduced. New risks related to tariff costs have emerged, although goodwill impairment indicators currently show a modest buffer.

Filing Documents

• esca20250930_10q.htm (10-Q) — 864KB
• ex_875008.htm (EX-31.1) — 12KB
• ex_875009.htm (EX-31.2) — 12KB
• ex_875010.htm (EX-32.1) — 5KB
• ex_875011.htm (EX-32.2) — 5KB
• 0001437749-25-032415.txt ( ) — 4540KB
• esca-20250930.xsd (EX-101.SCH) — 38KB
• esca-20250930_def.xml (EX-101.DEF) — 252KB
• esca-20250930_lab.xml (EX-101.LAB) — 215KB
• esca-20250930_pre.xml (EX-101.PRE) — 278KB
• esca-20250930_cal.xml (EX-101.CAL) — 37KB
• esca20250930_10q_htm.xml (XML) — 749KB

Financial Statements

Financial Statements: Consolidated Condensed Balance Sheets as of September 30, 2025, December 31, 2024, and September 30, 2024 3 Consolidated Condensed Statements of Operations for the Three Months and Nine Months Ended September 30, 2025 and September 30, 2024 4 Consolidated Condensed Statements of Stockholders' Equity for the Three Months and Nine Months Ended September 30, 2025 and September 30, 2024 5 Consolidated Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2025 and September 30, 2024 6 Notes to Consolidated Condensed Financial Statements 7 Item 2 -

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 15 Item 3 -

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 18 Item 4 -

Controls and Procedures

Controls and Procedures 18 Part II. Other Information Item 1 -

Legal Proceedings

Legal Proceedings 18 Item 1A -

Risk Factors

Risk Factors 18 Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds 19 Item 6 - Exhibits 20 Signature 20 2

- FINANCIAL INFORMATION

PART I - FINANCIAL INFORMATION

FINANCIAL STATEMENTS

Item 1. FINANCIAL STATEMENTS ESCALADE, INCORPORATED AND SUBSIDIARIES CONSOLIDATED CONDENSED BALANCE SHEETS All Amounts in Thousands Except Share Information September 30, 2025 December 31, 2024 September 30, 2024 (Unaudited) (Audited) (Unaudited) ASSETS Current Assets: Cash and cash equivalents $ 3,509 $ 4,194 $ 426 Receivables, less allowance of $ 957 ; $ 694 ; and $ 669 ; respectively 52,756 48,768 53,480 Inventories 80,662 76,025 85,485 Prepaid expenses 4,350 4,372 5,117 Prepaid income tax - 465 156 TOTAL CURRENT ASSETS 141,277 133,824 144,664 Property, plant and equipment, net 21,716 22,221 22,856 Operating lease right-of-use assets 1,347 1,186 7,640 Intangible assets, net 25,636 25,838 26,409 Goodwill 42,326 42,326 42,326 Other assets 158 935 1,035 TOTAL ASSETS $ 232,460 $ 226,330 $ 244,930 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Current portion of long-term debt $ 7,143 $ 7,143 $ 7,143 Trade accounts payable 21,119 11,858 19,965 Accrued liabilities 12,923 15,050 13,769 Income tax payable 1,169 - - Current operating lease liabilities 496 444 1,083 TOTAL CURRENT LIABILITIES 42,850 34,495 41,960 Other Liabilities: Longterm debt 13,095 18,452 22,353 Deferred income tax liability 3,302 3,302 3,125 Operating lease liabilities 886 787 7,125 Other liabilities - 297 297 TOTAL LIABILITIES 60,133 57,333 74,860 Stockholders' Equity: Preferred stock: Authorized 1,000,000 shares; no par value, none issued - - - Common stock: Authorized 30,000,000 shares; no par value, issued and outstanding – 13,803,745 ; 13,732,719 ; and 13,877,302 ; shares respectively 3,757 4,218 5,909 Retained earnings 168,570 164,779 164,161 TOTAL STOCKHOLDERS' EQUITY 172,327 168,997 170,070 TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 232,460 $ 226,330 $ 244,930

View Full Filing

View this 10-Q filing on SEC EDGAR